Description

Ibandronic Acid is a group of medicine called bisphosphonates. It alters the cycle of bone formation and break down in the body. It slows bone loss while increasing bones mass, which may prevent bone fracture. Ibandronic Acid has an affinity for hydroxyapatite crystals in bone and acts as a hydroxyapatite agent. At the cellular level, Ibandronic Acid inhibits osteoclast. The osteoclasts adhere normally to the bone surface but show evidence of reduce active resorption. Osteoporosis: Human body constantly breaking down old bone and making new bone tissue. If people have osteoporosis, their body breaks down more bones than it forms. So that gradually bone loss occurs and bones become thinner and fragile. This is especially common in women after the menopause. Many people with osteoporosis have no symptom and may not even know that they have it. However, osteoporosis makes them more likely to have fractures, especially in spine, hips and wrists.

Ibandronic Acid: Abnormalities of the esophagus, hypocalcemia, known hypersensitivity to Ibandronic Acid or any of its components. Calcium Orotate: Incomplete bowel movements, Kidney stone, Kidney disease and lung disease.

Ibandronic Acid: Common side effects include Hypertension, Dyspepsia, Nausea, Diarrhea, Abdominal Pain, Arthralgia, Back Pain, Localized Osteoarthritis, Myalgia, Muscle Cramp, Influenza, Nasopharyngitis, Bonchitis, Urinary Tract Infection, Upper Respiratory Tract Infection, Headache, Dizziness, Skin Rash, Insomnia etc. Calcium Orotate: Bloating and swelling in the abdomen are common side effects of Calcium Orotate, loss of appetite, upset stomach, constipation, nausea, vomiting, unusual weight loss, mood changes, bone/muscle pain, headache, increased thirst/urination, weakness, unusual tiredness, formation of kidney stones may occur infrequently.

There are no adequate and well-controlled studies in pregnant women for this kit. This kit should be used during pregnancy only if the potential benefit justifies the potential risk to the mother and fetus. It is not known whether this kit is excreted in human milk. Caution should be exercised when this kit is administered to a nursing woman.

Ibandronic Acid: Ibandronic Acid of this Kit may cause local irritation of the upper gastrointestinal mucosa. Adequate intake of Calcium is important in all patient hypocalcaemia Severe and occasionally incapacitating bone joint, and/or muscle pain has been reported in patients taking Ibandronic Acid. Ibandronic Acid is not recommended for use in patients with severe renal impairment (Creatinine clearance of <30 ml/min). Calcium Orotate: Before taking Calcium Orotate, precaution is needed if the patient is allergic to Calcium Orotate. Any Calcium supplement taken without food may increase the risk of kidney stones. Therefore, it is advisable that Calcium Orotate be taken with food.

Pediatric Use: Safety and effectiveness in pediatric patients have not been established. Renal and hepatic impaired patient: No dose adjustment is necessary for patients with mild or moderate renal impairment where creatinine clearance is equal to or greater than 30 ml/min. No dose adjustment is required for patients with hepatic impairment.

Minerals in bone formation, Specific mineral preparations